L P Ormerod

1.5k total citations
39 papers, 929 citations indexed

About

L P Ormerod is a scholar working on Infectious Diseases, Surgery and Epidemiology. According to data from OpenAlex, L P Ormerod has authored 39 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 21 papers in Surgery and 19 papers in Epidemiology. Recurrent topics in L P Ormerod's work include Tuberculosis Research and Epidemiology (25 papers), Infectious Diseases and Tuberculosis (13 papers) and Diagnosis and treatment of tuberculosis (13 papers). L P Ormerod is often cited by papers focused on Tuberculosis Research and Epidemiology (25 papers), Infectious Diseases and Tuberculosis (13 papers) and Diagnosis and treatment of tuberculosis (13 papers). L P Ormerod collaborates with scholars based in United Kingdom, United States and Bulgaria. L P Ormerod's co-authors include V. M. Yates, R. J. Prescott, Stephen Hodgson, Jayapal Ramesh, John Friend, Jeannine Garnett, Peter Jenkins, I. A. Campbell, Robert F. Miller and Simon Collins and has published in prestigious journals such as European Heart Journal, The British Journal of Psychiatry and European Respiratory Journal.

In The Last Decade

L P Ormerod

39 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L P Ormerod United Kingdom 18 639 555 475 59 47 39 929
J. O. M. Pobee Zambia 14 691 1.1× 393 0.7× 583 1.2× 45 0.8× 41 0.9× 26 1.1k
Salah-Eddine Ottmani Switzerland 13 1.0k 1.6× 482 0.9× 837 1.8× 25 0.4× 35 0.7× 16 1.2k
Elena S. Hollender United States 10 691 1.1× 510 0.9× 700 1.5× 29 0.5× 39 0.8× 10 1.0k
N. Mémain France 9 371 0.6× 222 0.4× 392 0.8× 92 1.6× 38 0.8× 16 685
Rupak Singla India 17 582 0.9× 292 0.5× 454 1.0× 19 0.3× 78 1.7× 51 789
Rosie Burton South Africa 18 689 1.1× 274 0.5× 593 1.2× 50 0.8× 21 0.4× 38 979
Annette Haberl Germany 18 499 0.8× 125 0.2× 310 0.7× 154 2.6× 43 0.9× 56 868
Martine G. Aabye Denmark 17 634 1.0× 325 0.6× 527 1.1× 60 1.0× 87 1.9× 26 827
Rocio Hurtado United States 15 530 0.8× 297 0.5× 393 0.8× 37 0.6× 27 0.6× 46 729
José Mayo Spain 16 283 0.4× 116 0.2× 208 0.4× 143 2.4× 20 0.4× 33 639

Countries citing papers authored by L P Ormerod

Since Specialization
Citations

This map shows the geographic impact of L P Ormerod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L P Ormerod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L P Ormerod more than expected).

Fields of papers citing papers by L P Ormerod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L P Ormerod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L P Ormerod. The network helps show where L P Ormerod may publish in the future.

Co-authorship network of co-authors of L P Ormerod

This figure shows the co-authorship network connecting the top 25 collaborators of L P Ormerod. A scholar is included among the top collaborators of L P Ormerod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L P Ormerod. L P Ormerod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zenner, Dominik, Miranda G. Loutet, Ross Harris, Stephen Wilson, & L P Ormerod. (2017). Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation. European Respiratory Journal. 50(1). 1602505–1602505. 22 indexed citations
2.
Bright-Thomas, R.J., et al.. (2016). Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period. The International Journal of Tuberculosis and Lung Disease. 20(12). 1621–1624. 11 indexed citations
3.
Pozniak, A L, Robert F. Miller, Marc Lipman, et al.. (2011). British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. HIV Medicine. 12(9). 517–524. 89 indexed citations
4.
Bright-Thomas, R.J., et al.. (2010). Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children. Archives of Disease in Childhood. 95(8). 600–602. 34 indexed citations
5.
Ramesh, Jayapal, et al.. (2008). Abdominal tuberculosis in a district general hospital: a retrospective review of 86 cases. QJM. 101(3). 189–195. 48 indexed citations
6.
Ibrahim, Nader, et al.. (2005). Segmental pulmonary veno-occlusive disease secondary to lung cancer. Journal of Clinical Pathology. 58(4). 434–436. 9 indexed citations
7.
Pozniak, A L, Robert F. Miller, Marc Lipman, et al.. (2005). BHIVA treatment guidelines for TB/HIV infection. 12 indexed citations
8.
Ormerod, L P & RJ Prescott. (2003). The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. Clinical Medicine. 3(1). 57–61. 11 indexed citations
9.
Ormerod, L P. (1999). Directly observed therapy (DOT) for tuberculosis: why, when, how and if?. Thorax. 54(Supplement 2). S42–S45. 22 indexed citations
10.
Grange, J.M., M.D. Yates, & L P Ormerod. (1995). Factors determining ethnic differences in the incidence of bacteriologically confirmed genitourinary tuberculosis in South East England. Journal of Infection. 30(1). 37–40. 10 indexed citations
11.
Ormerod, L P, et al.. (1994). Recurrent Sinus Arrest in Association with Neuroleptic Malignant Syndrome. The British Journal of Psychiatry. 164(5). 689–691. 7 indexed citations
12.
Ormerod, L P. (1993). Results of tuberculosis contact tracing: Blackburn 1982–1990. Respiratory Medicine. 87(2). 127–131. 22 indexed citations
13.
Campbell, I. A., L P Ormerod, John Friend, Peter Jenkins, & R. J. Prescott. (1993). Six months versus nine months chemotherapy for tuberculosis of lymph nodes: Final results. Respiratory Medicine. 87(8). 621–623. 63 indexed citations
14.
Myers, Paul J. & L P Ormerod. (1992). Increased asthma admission rates in Asian patients: Blackburn 1987. Respiratory Medicine. 86(4). 297–300. 15 indexed citations
15.
Ormerod, L P & R. J. Prescott. (1991). Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respiratory Medicine. 85(3). 239–242. 35 indexed citations
16.
17.
Ormerod, L P. (1989). Mycobacterium tuberculosis infection. Current Opinion in Infectious Diseases. 2(4). 552–554. 1 indexed citations
18.
Ormerod, L P. (1988). A retrospective comparison of two drug regimens RHE2/RH10 and RHZ2/RH10 in the treatment of tuberculous mediastinal lymphadenopathy. British Journal of Diseases of the Chest. 82(3). 274–281. 6 indexed citations
19.
Ormerod, L P, et al.. (1985). Gastrointestinal Tuberculosis: A Retrospective Review of 109 Cases in a District General Hospital. QJM. 56(221). 569–78. 51 indexed citations
20.
Quyyumi, A. A., L P Ormerod, S W Clarke, T R Evans, & Robyn L. Ward. (1983). Pulmonary fibrosis—a serious side-effect of amiodarone therapy. European Heart Journal. 4(7). 521–524. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. O. M. Pobee Breakdown of academic impact, for papers by Salah-Eddine Ottmani Breakdown of academic impact, for papers by Elena S. Hollender Breakdown of academic impact, for papers by N. Mémain Breakdown of academic impact, for papers by Rupak Singla Breakdown of academic impact, for papers by Rosie Burton Breakdown of academic impact, for papers by Annette Haberl Breakdown of academic impact, for papers by Martine G. Aabye Breakdown of academic impact, for papers by Rocio Hurtado Breakdown of academic impact, for papers by José Mayo
Rankless by CCL
2026